<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20210503051169N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2021-07-17</date_registration>
      <primary_sponsor>Esfahan University of Medical Sciences</primary_sponsor>
      <public_title>Evaluation of the relationship between end tidal carbon dioxide pressure and the incidence of severe nausea and vomiting after general anesthesia in laparoscopic cholecystectomy</public_title>
      <acronym></acronym>
      <scientific_title>Evaluation of the relationship between end tidal carbon dioxide pressure and the incidence of severe nausea and vomiting after general anesthesia in laparoscopic cholecystectomy</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2021-07-16</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>88</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/56138</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Triple blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Random sequence (blocking) is generated by the help of Excel software and blocks of four are used to equalize the two groups so that the groups 1 and 2  of each person included in the study, can be determined randomly and equally. The  blocks of four are separated from the samples and placed in the block randomly by the Excel software of group A or B. At the end, it is determined which letter represents the intervention group 1 and 2, Blinding description: The participant (patient) is not aware of which group they are in. The clinical caregiver adjusts the capnograph to one of two groups according to the randomization.
Without knowing the grouping of people after the operation, the evaluator completes the outcome with a questionnaire without personal information. The questionnaires are given to the researcher in the form of A and B who do not know which is the first or second group.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Evaluation of the relationship between end tidal carbon dioxide pressure and the incidence of severe nausea and vomiting after general anesthesia in laparoscopic cholecystectomy.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: The first group of people undergoing laparoscopic cholecystectomy, which is maintained by a capnograph of the end-tidal carbon dioxide level between 35-40 mm Hg. Intervention 2: Intervention group: The second group of people underwent laparoscopic cholecystectomy, which is maintained by a capnograph of the end-tidal carbon dioxide level between 40-45 mm Hg.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Only registered marks can be published without mentioning the names of the participants

When:
6 months after printing the results

To whom:
It will be available only to researchers working in academic and scientific institutions

Conditions:
Written request by e-mail and approval of the Vice Chancellor for Research

Where to obtain:
By correspondence with the responsible author via email

How to obtain:
The applicant will be notified within one week of receiving the consent from the university,Maximum access takes 10 business days

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Dr.Khosro Naghibi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No. 17, Hezar Jarib St., Sepahan Alley, 6th St.</address>
        <city>Esfahan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>8175675333</zip>
        <telephone>+98 31 3670 2548</telephone>
        <email>khnaghibi@gmail.com</email>
        <affiliation>Esfahan University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Dr.Khosro Naghibi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No. 17, Hezar Jarib St., Sepahan Alley, 6th St.</address>
        <city>Esfahan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>8175675333</zip>
        <telephone>+98 31 3670 2548</telephone>
        <email>khnaghibi@gmail.com</email>
        <affiliation>Esfahan University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>88 candidates for laparoscopic cholecystectomy with ASA1,2 in the age group of 18-65 years</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>65 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Patients with ASA 3 and 4
Severe underlying disease such as heart failure, COPD, ESRD
History of motion sickness and history of postoperative nausea and vomiting
Allergy to anesthesia</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: The first group of people undergoing laparoscopic cholecystectomy, which is maintained by a capnograph of the end-tidal carbon dioxide level between 35-40 mm Hg.</i_keyword>
      <i_keyword>Intervention group: The second group of people underwent laparoscopic cholecystectomy, which is maintained by a capnograph of the end-tidal carbon dioxide level between 40-45 mm Hg.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Determining and comparing the frequency of postoperative nausea and vomiting in two groups with expiratory end carbon dioxide pressure of 40-40 and 40-45. Timepoint: Every 15 minutes in recovery 2, 4 and 6 hours after surgery. Method of measurement: Through a questionnaire.</prim_outcome>
      <prim_outcome>Determining and comparing the average dose of antiemetic drugs in two groups with expiratory carbon dioxide pressure of 40-40 and 45-40. Timepoint: At recovery time 2, 4 and 6 hours after surgery. Method of measurement: Through a questionnaire.</prim_outcome>
      <prim_outcome>Determining and comparing the average dose of opioids in two groups with expiratory end carbon dioxide pressure of 35-40 and 40-45. Timepoint: At recovery time 2, 4 and 6 hours after surgery. Method of measurement: Through a questionnaire.</prim_outcome>
      <prim_outcome>Determination and comparison of pain intensity during recovery in two groups with expiratory end of carbon dioxide pressure of 35-40 and 40-45. Timepoint: 2, 4 and 6 hours after surgery. Method of measurement: Based on VAS.</prim_outcome>
      <prim_outcome>Determining and comparing the average level of patient satisfaction in two groups with expiratory end carbon dioxide pressure of 40-40 and 45-40. Timepoint: In 6 hours after surgery. Method of measurement: Based on VAS.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Determination and comparison of mean arterial blood pressure, oxygen saturation and heart rate in two groups with expiratory end carbon dioxide pressure of 40-40 and 45-40. Timepoint: Basically then every half hour during surgery and recovery. Method of measurement: Through a questionnaire.</sec_outcome>
      <sec_outcome>Determining and comparing the duration of anesthesia and the duration of recovery surgery (duration of extubation) in two groups with expiratory end carbon dioxide pressure of 35-40 and 40-45. Timepoint: end of surgery. Method of measurement: Through a questionnaire.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Esfahan University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2021-04-30</approval_date>
        <contact_name>Ethics Committee of Isfahan University of Medical Sciences</contact_name>
        <contact_address>No.87, 3rdAlley, Golestan, Apadana St,1stAlley, Feiz square, Isfahan, Iran Esfahan Isfehan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
